Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.76
-0.33 (-1.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
Immunome Market Cap
Immunome has a market cap or net worth of $1.81 billion as of December 5, 2025. Its market cap has increased by 209.20% in one year.
Market Cap
1.81B
Enterprise Value
1.54B
1-Year Change
209.20%
Ranking
Category
Stock Price
$19.76
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $1.81B, an increase of 1,526.88%. That is a compound annual growth rate of 71.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.81B | 173.39% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |